KR101990456B1 - Method for producing balloonflower tea of teabag-type and balloonflower tea of teabag-type produced by the same method - Google Patents
Method for producing balloonflower tea of teabag-type and balloonflower tea of teabag-type produced by the same method Download PDFInfo
- Publication number
- KR101990456B1 KR101990456B1 KR1020180061883A KR20180061883A KR101990456B1 KR 101990456 B1 KR101990456 B1 KR 101990456B1 KR 1020180061883 A KR1020180061883 A KR 1020180061883A KR 20180061883 A KR20180061883 A KR 20180061883A KR 101990456 B1 KR101990456 B1 KR 101990456B1
- Authority
- KR
- South Korea
- Prior art keywords
- tea
- balloonflower
- bellflower
- prepared
- teabag
- Prior art date
Links
- 244000269722 Thea sinensis Species 0.000 title abstract description 56
- 238000004519 manufacturing process Methods 0.000 title abstract description 19
- 235000006753 Platycodon grandiflorum Nutrition 0.000 title abstract 8
- 240000003582 Platycodon grandiflorus Species 0.000 title abstract 8
- 238000000034 method Methods 0.000 title description 11
- 239000000284 extract Substances 0.000 claims abstract description 40
- 239000000203 mixture Substances 0.000 claims abstract description 27
- 241000241413 Propolis Species 0.000 claims abstract description 14
- 229940069949 propolis Drugs 0.000 claims abstract description 14
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 11
- 235000018865 Angelica gigas Nutrition 0.000 claims abstract description 10
- 240000001810 Angelica gigas Species 0.000 claims abstract description 10
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims abstract description 10
- 235000011941 Tilia x europaea Nutrition 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 10
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 235000008216 herbs Nutrition 0.000 claims abstract description 4
- 241000332371 Abutilon x hybridum Species 0.000 claims description 48
- 241000411851 herbal medicine Species 0.000 claims description 16
- 208000023504 respiratory system disease Diseases 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 239000012676 herbal extract Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 18
- 238000007789 sealing Methods 0.000 abstract description 7
- 235000019658 bitter taste Nutrition 0.000 abstract description 6
- 230000002829 reductive effect Effects 0.000 abstract description 5
- 235000019640 taste Nutrition 0.000 abstract description 5
- 238000000227 grinding Methods 0.000 abstract description 2
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241001532026 Liriope muscari Species 0.000 abstract 1
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 235000004348 Perilla frutescens Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 49
- 230000000052 comparative effect Effects 0.000 description 21
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 9
- 206010036790 Productive cough Diseases 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 208000024794 sputum Diseases 0.000 description 9
- 210000003802 sputum Anatomy 0.000 description 9
- 230000000845 anti-microbial effect Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 6
- 240000003553 Leptospermum scoparium Species 0.000 description 6
- 235000015459 Lycium barbarum Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 4
- 241000588747 Klebsiella pneumoniae Species 0.000 description 4
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 4
- 241000208422 Rhododendron Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 238000007598 dipping method Methods 0.000 description 4
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 3
- 240000002045 Guettarda speciosa Species 0.000 description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 241000193996 Streptococcus pyogenes Species 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 241000092897 Angelica japonica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000234280 Liliaceae Species 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940096118 ella Drugs 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 2
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 241001105098 Angelica keiskei Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 235000006751 Platycodon Nutrition 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 206010037368 Pulmonary congestion Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- -1 and then the color Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 229930189914 platycodon Natural products 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/30—Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/22—Drying or concentrating tea extract
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
- B65D85/804—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
- B65D85/808—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package for immersion in the liquid to release part or all of their contents, e.g. tea bags
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mechanical Engineering (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
본 발명은 (1) 당귀, 천궁, 자소엽 및 맥문동을 혼합한 한약재에 물을 첨가한 후 추출하고 여과하여 한약재 추출물을 제조하는 단계; (2) 상기 (1)단계의 제조한 한약재 추출물에 라임 즙액 및 프로폴리스 추출물을 혼합한 혼합물을 준비하는 단계; (3) 도라지를 상기 (2)단계의 준비한 혼합물에 침지한 후 꺼내는 단계; (4) 상기 (3)단계의 꺼낸 생도라지를 건조하는 단계; 및 (5) 상기 (4)단계의 건조한 도라지를 볶고 분쇄한 후 티백에 담아 봉하는 단계를 포함하여 제조하는 것을 특징으로 하는 도라지 티백차의 제조방법 및 상기 방법으로 제조된 도라지 티백차에 관한 것이다.(1) preparing a herbal extract by adding water to a herb medicine mixed with Angelica keiskei, Angelicae radix; (2) preparing a mixture of the lime juice extract and the propolis extract in the herbal medicine extract prepared in the step (1); (3) dipping the bellflower in the mixture prepared in the step (2) and removing the bellflower; (4) drying the drawn rhizome of the step (3); And (5) frying and pulverizing the dried bellflower in the step (4), and then filling the bellflower in a tea bag and sealing the dried bellflower, wherein the bellflower tea bag is manufactured by the method .
도라지는 당질, 칼슘, 철분, 비타민 B, 비타민 C 및 인삼의 주요 성분 중 하나인 사포닌을 다량 함유하고 있어, 한방에서는 기관지염, 편도선염 등에 대한 항염증, 거담, 항궤양, 진해, 해열, 진통 등의 효과를 위한 약재로 사용되기도 한다. 또한, 도라지에 함유된 물질들은 곰팡이의 독소 생성을 감소시키며, 실험동물에 투여했을 때 식균작용을 촉진하였을 뿐 아니라, 도라지에 함유된 이눌린 성분은 생쥐를 이용한 항암실험에서 강력한 항암활성을 보인다는 것이 확인되었다. 이눌린은 혈당을 강화하고, 장을 튼튼하게 하며 숙취해소에도 효과가 있는 것으로 알려져 있다.The bellflower contains a large amount of saponin, which is one of the major components of carbohydrate, calcium, iron, vitamin B, vitamin C and ginseng. Therefore, the bellflower contains anti-inflammatory, gonadal, antiulcer, It is also used as a medicinal product for the effect. In addition, the substances contained in the bellflower reduced the production of toxins of fungi, and not only promoted the phagocyte action when administered to experimental animals, but also that the inulin component contained in the bellflower exhibited strong anticancer activity in mice . Inulin is known to strengthen blood sugar, strengthen the intestines and help relieve hangovers.
도라지는 인삼에 비하여 비교적 가격이 저렴하고 일반인들이 손쉽게 구할 수 있기 때문에 인삼대용의 건강식품으로 즐겨 먹게 되었으며, 오래 복용하면 보약으로서 좋다고 알려져 있다. 그러나 도라지는 쓴맛이 있어 그대로 사용할 경우, 쓴맛으로 인해 섭취를 기피할 수 있어 이러한 단점을 보완할 필요가 있다.Bellflower is relatively cheaper than ginseng and can be obtained easily by ordinary people, so it is eaten as a healthy food substitute for ginseng, and it is said that it is good as a preservative if taken for a long time. However, since the bellflower has a bitter taste and can be used as it is, it can avoid consumption due to its bitter taste, and it is necessary to compensate for such disadvantages.
호흡기질환으로는 감기, 기관지염, 폐렴, 결핵, 폐암 및 만성기관지염 등이 대표적이다. 상기 호흡기질환들의 대표적이면서도 공통적으로 보이는 증상이 바로 기침 또는 가래가 발생하는 것이다. 기침은 폐포 내의 공기가 기도를 통하여 폭발적으로 소리를 내며 튀어나오는 현상으로서, 주로 목, 기관, 기관지 등의 기도점막에 분포되어 있는 미주신경의 말초가 자극을 받아 해수 중추가 흥분됨으로써 일어나는 현상이다. 기침은 건성과 습성으로 대별되는바, 건성은 가래를 동반하지 않는 것인데, 기관지염에서 기관지의 충혈, 부종 등에 의한 자극으로 일어나는 것과 기도 이외의 미주신경 지배 영역의 자극으로 일어나는 것이 있으며, 자극성 해수 또는 마른 기침이라고도 한다. 습성은 가래를 동반하는 것으로 기관지와 폐의 염증에 의한 삼출액(出液)의 자극으로 일어나며, 기도 내의 병적 분비물을 몸 밖으로 배출하는데 도움이 된다. 기침은 원래 폐를 유해물질의 침입으로부터 방어하는 중요한 방어기능으로 간주된다. 그러나 기도에 염증 등이 생기면 그 자체가 자극이 되어 질병이 계속되는 한 기침이 일어난다. 이렇게 되면 이미 본래의 방어적인 의미는 사라지고 환자를 괴롭히는 증세로 나타난다. 치료는 기침을 유발하는 원인부터 제거해야 하지만, 빈발하는 기침을 억제하기 위하여 안정을 취하고, 방안을 따뜻하게 하며, 코로 호흡하여 자극을 피하도록 하는 것이다. 가래는 기침에 의하여 뱉아 낸 기도의 분비물로서, 담(痰) 또는 객담(喀痰)이라고도 한다. 원래는 기도 점막의 보호물질이지만, 외부환경 또는 질병으로 말미암아 분비량이 많아지거나 천식의 경우 농도가 짙어져서 고통을 받는 한 원인이 되는 수가 있다. 가래는 외관상 물 같은 것, 점액성인 것, 고름 모양인 것, 혈액이 섞인 것 등으로 나눌 수 있다. 폐수종과 같이 폐에 울혈이 생긴 경우에는 묽은 장액성 가래가 많이 나오고, 기관지염, 폐결핵, 폐렴의 초기에는 점액성, 기관지 확장증, 폐농양, 폐괴저 등에서는 고름 모양의 가래가 나온다.Respiratory diseases include colds, bronchitis, pneumonia, tuberculosis, lung cancer, and chronic bronchitis. A typical and common symptom of respiratory diseases is cough or sputum. Cough is a phenomenon in which the air in the alveoli bursts out through the airways. It is caused by the stimulation of the central nervous system, which is distributed in the airway mucosa of the neck, organs, bronchi, Cough is divided into dryness and dryness. Dryness is not accompanied by sputum. It is caused by stimulation by bronchial hyperemia and edema in bronchial inflammation, and by stimulation of vagal nerve area other than airway. Also called cough. The habit is accompanied by sputum, which is caused by stimulation of the effusion caused by inflammation of the bronchi and the lungs, and helps to discharge the pathological secretions in the air. Coughing is considered to be an important defense against the intrusion of harmful substances into the lungs. However, when the airway is inflamed, the cough occurs as the disease itself continues to be stimulated. In this way, the original defensive meaning disappears and appears to be a symptom that afflicts the patient. Treatment should remove the cause of the cough, but to prevent frequent cough, take the stability, warm the room, and the nose is to avoid stimulation by breathing. Sputum is a secretion of the airways spit out by coughing, and it is also known as sputum or sputum. Originally, it is a protective substance for the airway mucosa, but it can cause pain due to increased secretion due to external environment or disease, or thickening of asthma. Sputum can be divided into two types: water in appearance, mucous, pus-shaped, and blood-mixed. When lung congestion occurs like lung adenocarcinoma, a lot of dilute serous sputum emerges. In the early days of bronchitis, pulmonary tuberculosis, and pneumonia, mucus, bronchiectasis, lung abscess, and lung gangrene are pus-shaped sputum.
호흡기질환 환자들로부터 분리되는 병원성 박테리아로써, 이를 치료하기 위해 페니실린, β-락탐(β-lactam)과 같은 광범위 항생제가 사용되고 있으나, 무분별한 항생제의 남용으로 β-락타마아제(β-lactamase)와 같은 내성 물질을 생성하는 항생제 내성 균주가 생기는 것으로 알려져 있다.A wide range of antibiotics such as penicillin and β-lactam have been used to treat the pathogenic bacteria isolated from patients with respiratory diseases. However, as a result of indiscriminate use of antibiotics, β-lactamase It is known that an antibiotic resistant strain producing a resistant substance is produced.
한국등록특허 제0936156호에는 볶은 도라지에 현미, 옥수수, 메밀 또는 녹차를 포함하는 도라지 티백차의 제조방법이 개시되어 있고, 한국등록특허 제1509236호에는 연근, 우엉, 도라지 및 마를 이용한 차의 제조방법이 개시되어 있으나, 본 발명의 침출 효율도 높고 호흡기질환 유발 세균에 대한 항균 활성이 우수한 도라지 티백차는 개시된 바 없다.Korean Patent No. 0936156 discloses a method for manufacturing a bellflower tea bag containing brown rice, corn, buckwheat or green tea in roasted bellflower, and Korean Patent No. 1509236 discloses a method for producing tea using a lotus root, burdock, However, there has been no disclosure of Dorago tea bag having a high leaching efficiency and excellent antimicrobial activity against respiratory disease-causing bacteria of the present invention.
본 발명은 상기와 같은 요구에 의해 안출된 것으로서, 본 발명의 목적은 도라지 전처리, 건조, 볶음처리 등의 제조조건을 최적화하여, 도라지 쓴맛은 감소되고 부드러운 맛이 증가할 뿐만 아니라, 침출 효율도 높고 호흡기질환 유발 세균에 대한 항균 활성이 우수한 도라지 티백차의 제조방법을 제공하는 데 있다.SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned needs, and it is an object of the present invention to provide a process for producing a fermented soybean paste which is capable of optimizing production conditions such as platycodon treatment, drying and roasting treatment, Which is excellent in antimicrobial activity against respiratory disease-causing bacteria.
상기 과제를 해결하기 위해, 본 발명은 (1) 당귀, 천궁, 자소엽 및 맥문동을 혼합한 한약재에 물을 첨가한 후 추출하고 여과하여 한약재 추출물을 제조하는 단계; (2) 상기 (1)단계의 제조한 한약재 추출물에 라임 즙액 및 프로폴리스 추출물을 혼합한 혼합물을 준비하는 단계; (3) 도라지를 상기 (2)단계의 준비한 혼합물에 침지한 후 꺼내는 단계; (4) 상기 (3)단계의 꺼낸 생도라지를 건조하는 단계; 및 (5) 상기 (4)단계의 건조한 도라지를 볶고 분쇄한 후 티백에 담아 봉하는 단계를 포함하여 제조하는 것을 특징으로 하는 도라지 티백차의 제조방법을 제공한다.In order to solve the above-mentioned problems, the present invention provides a method for producing a medicinal herb composition comprising the steps of: (1) preparing a medicinal herb extract by adding water to a medicinal herb mixed with Angelica gigas, Angelicae radix; (2) preparing a mixture of the lime juice extract and the propolis extract in the herbal medicine extract prepared in the step (1); (3) dipping the bellflower in the mixture prepared in the step (2) and removing the bellflower; (4) drying the drawn rhizome of the step (3); And (5) frying and pulverizing dried bellflower in the step (4), and sealing the bellflower in a tea bag, and then sealing the dried bellflower.
본 발명은 또한, 상기 방법으로 제조된 도라지 티백차를 제공한다.The present invention also provides a strawberry tea bag manufactured by the above method.
본 발명의 도라지 티백차는 도라지 쓴맛은 감소되고 부드러운 맛이 증가할 뿐만 아니라, 온수뿐만 아니라 냉수에도 추출 효율이 높은 이점이 있다. 또한, 호흡기질환 유발 세균에 대한 항균 활성이 우수하여 호흡기질환 예방 또는 개선을 위한 식품으로 유용하게 이용할 수 있는 이점이 있다.The tea tree tea of the present invention has an advantage in that the bitterness of bellflower is reduced and the soft taste is increased, and the extraction efficiency is high not only in hot water but also in cold water. In addition, there is an advantage that it is useful as a food for prevention or improvement of respiratory diseases because of its excellent antimicrobial activity against respiratory disease-causing bacteria.
도 1은 각각의 시료가 첨가된 NB 배지에 (A) 스트렙토코커스 피로게네스(Streptococcus pyrogenes), (B) 크렙시엘라 뉴모니아(Klebsiella pneumonia), (C) 스타필로코커스 아우레우스(Staphylococcus aureus), (D) 코리네박테리움 디프테리아(Corynebacterium diphtheriae) 배양액을 혼합하여 24시간 배양한 후 흡광도 변화를 비교한 그래프이다.Figure 1 (A) Streptococcus fatigue to Ness (Streptococcus pyrogenes), (B) keurep when Ella pneumoniae (Klebsiella pneumonia), (C) Staphylococcus aureus (Staphylococcus on NB medium supplemented with each sample was added aureus), (D) Corynebacterium diphtheria (Corynebacterium diphtheriae cultures for 24 hours.
본 발명의 목적을 달성하기 위하여, 본 발명은In order to achieve the object of the present invention,
(1) 당귀, 천궁, 자소엽 및 맥문동을 혼합한 한약재에 물을 첨가한 후 추출하고 여과하여 한약재 추출물을 제조하는 단계;(1) preparing a medicinal herb extract by adding water to an oriental medicinal herb mixed with Angelicae gigantis, Angelica gigas, Liliaceous gyrus, and Rhododendron;
(2) 상기 (1)단계의 제조한 한약재 추출물에 라임 즙액 및 프로폴리스 추출물을 혼합한 혼합물을 준비하는 단계;(2) preparing a mixture of the lime juice extract and the propolis extract in the herbal medicine extract prepared in the step (1);
(3) 도라지를 상기 (2)단계의 준비한 혼합물에 침지한 후 꺼내는 단계;(3) dipping the bellflower in the mixture prepared in the step (2) and removing the bellflower;
(4) 상기 (3)단계의 꺼낸 생도라지를 건조하는 단계; 및(4) drying the drawn rhizome of the step (3); And
(5) 상기 (4)단계의 건조한 도라지를 볶고 분쇄한 후 티백에 담아 봉하는 단계를 포함하여 제조하는 것을 특징으로 하는 도라지 티백차의 제조방법을 제공한다.(5) frying the dried bellflower in the step (4), pulverizing it, and sealing the bellflower in a tea bag and then sealing the bellflower tea bag.
본 발명의 도라지 티백차의 제조방법에서, 상기 (1)단계의 한약재 추출물은 바람직하게는 당귀 3.5~4.5 kg, 천궁 3.5~4.5 kg, 자소엽 0.8~1.2 kg 및 맥문동 0.8~1.2 kg을 혼합한 한약재에 물을 8~12배(v/w) 첨가한 후 80~90℃에서 10~14시간 동안 추출하고 여과하여 제조할 수 있으며, 더욱 바람직하게는 당귀 4 kg, 천궁 4 kg, 자소엽 1 kg 및 맥문동 1 kg을 혼합한 한약재에 물을 10배(v/w) 첨가한 후 85℃에서 12시간 동안 추출하고 여과하여 제조할 수 있다. 상기와 같은 조건으로 제조된 한약재 추출물은 도라지와 잘 어우러져 차의 풍미를 풍부하게 하여 기호도가 우수하고 항균 활성을 증진시켜 품질이 우수한 도라지 티백차로 제조할 수 있었다.In the method for producing the tea tree tea bag of the present invention, the herbal medicine extract of step (1) is preferably prepared by mixing 3.5 to 4.5 kg of Angelica gigas Nakai, 3.5 to 4.5 kg of Angelica gigas Nakai, 0.8 to 1.2 kg of hemp leaf and 0.8 to 1.2 kg It can be prepared by adding water to the herbal medicine 8 to 12 times (v / w) and then extracting it at 80 to 90 ° C for 10 to 14 hours and filtering. More preferably, 4 kg of Angelica gigantis, 4 kg of Angelicae, (v / w) of water and then extracted at 85 ° C for 12 hours and filtered. The medicinal herb extract prepared under the above conditions was well mixed with the bellflower to enhance the flavor of the tea, and thus it was able to be produced as a Doraji tea bag having excellent quality and excellent antimicrobial activity.
또한, 본 발명의 도라지 티백차의 제조방법에서, 상기 (2)단계의 혼합물은 바람직하게는 한약재 추출물 70~90 L에 라임 즙액 8~12 L 및 프로폴리스 추출물 8~12 L를 혼합하여 제조할 수 있으며, 더욱 바람직하게는 한약재 추출물 80 L에 라임 즙액 10 L 및 프로폴리스 추출물 10 L를 혼합하여 제조할 수 있다. 상기와 같은 재료 및 배합비로 제조된 혼합물을 이용하여 도라지를 전처리하는 것이 도라지 특유의 아린맛 및 쓴맛은 제거되고 향미가 증진되어 음용이 용이할 뿐만 아니라, 항균 활성이 증진된 도라지 차로 제조할 수 있었다.In addition, in the method for producing the tea tree tea bag of the present invention, the mixture of step (2) is preferably prepared by mixing 8 to 12 L of lime juice and 8 to 12 L of propolis extract with 70 to 90 L of the herbal medicine extract More preferably, it can be prepared by mixing 10 L of lime juice and 10 L of propolis extract with 80 L of the herbal medicine extract. Pre-treatment of the bellflower using the mixture prepared by the above-mentioned materials and the blending ratios can be carried out by using the bellflower tea which has an aromatic and bitter taste unique to the bellflower and has an improved flavor and an improved antimicrobial activity .
상기 라임 즙액은 라임 열매를 착즙한 액을 의미하며, 상기 프로폴리스 추출물은 바람직하게는 프로폴리스 원괴와 80~90% 주정을 0.8~1.2:0.8~1.2 중량비율로 혼합한 후 20~25℃에서 20~40일 동안 추출한 후 여과하여 제조할 수 있으며, 더욱 프로폴리스 원괴와 85% 주정을 1:1 중량비율로 혼합한 후 20~25℃에서 30일 동안 추출한 후 여과하여 제조할 수 있다.The propolis extract is preferably prepared by mixing 80 to 90% alcohol with 0.8 to 1.2: 0.8 to 1.2% by weight of the propolis extract and stirring at 20 to 25 ° C 20 to 40 days, and then filtering. Further, the propolis raw material and the 85% alcohol may be mixed at a weight ratio of 1: 1, and the mixture may be extracted at 20 to 25 ° C for 30 days and then filtered.
또한, 본 발명의 도라지 티백차의 제조방법에서, 상기 (3)단계의 침지는 바람직하게는 20~25℃에서 5~7시간 동안 침지할 수 있으며, 더욱 바람직하게는 20~25℃에서 6시간 동안 침지할 수 있다. 상기와 같은 조건으로 도라지를 혼합물에 침지하는 것이 향기와 맛이 살아나 더욱 깊은 풍미를 지닐뿐만 아니라, 혼합물의 맛과 향이 도라지와 잘 조화를 이루고, 추출 효율 및 항균 활성도 더욱 증진시킬 수 있었다.In the method for producing the tea tree tea bag according to the present invention, the immersion in the step (3) is preferably carried out at 20 to 25 ° C for 5 to 7 hours, more preferably 20 to 25 ° C for 6 hours Lt; / RTI > Dipping the mixture into the mixture under the above conditions not only has a higher flavor and flavor but also improves the extraction efficiency and antibacterial activity of the mixture and the flavor and aroma of the mixture.
또한, 본 발명의 도라지 티백차의 제조방법에서, 상기 (4)단계의 건조는 바람직하게는 55~60℃에서 20~28시간 동안 건조할 수 있으며, 더욱 바람직하게는 55~60℃에서 24시간 동안 건조할 수 있다. 상기와 같은 조건으로 건조함으로써 도라지 차의 맛을 더욱 무르익게 하고 향기가 더욱 오래 지속되도록 건조할 수 있었다.Further, in the process for producing the tea tree tea bag of the present invention, drying in the step (4) is preferably performed at 55 to 60 ° C for 20 to 28 hours, more preferably at 55 to 60 ° C for 24 hours Lt; / RTI > By drying under the same conditions as above, the taste of the Doragi tea could be further ripened and the flavor could be dried for a longer period of time.
또한, 본 발명의 도라지 티백차의 제조방법에서, 상기 (5)단계의 볶는 조건은 바람직하게는 7~10 kg/cm2 압력 및 90~120℃ 온도에서 8~12분 동안 볶을 수 있으며, 더욱 바람직하게는 8.5 kg/cm2 압력 및 105℃ 온도에서 10분 동안 볶을 수 있다. 상기와 같은 조건으로 볶음으로써 고소한 맛과 향이 잘 살아나고 추출 효율이 더 증진된 티백차로 제조할 수 있었다. 그러나 볶는 조건이 상기 조건을 벗어나는 경우 고소한 맛이 감소하거나 탄맛이 나서 기호도가 감소하는 문제점이 있다.In addition, in the process for producing the tea tree tea bag of the present invention, the roasting condition of the step (5) may be roasted preferably at a pressure of 7 to 10 kg / cm 2 and at a temperature of 90 to 120 ° C for 8 to 12 minutes, Preferably at a pressure of 8.5 kg / cm < 2 > and a temperature of 105 DEG C for 10 minutes. By the above-mentioned conditions, it was possible to produce a tea bag having a higher flavor and aroma and a higher extraction efficiency by stirring. However, when the roasting condition is out of the above-mentioned condition, there is a problem that the flavor is reduced or the taste is reduced and the preference degree is decreased.
본 발명의 도라지 티백차의 제조방법은, 보다 구체적으로는The method of manufacturing a donut tea bag according to the present invention, more specifically,
(1) 당귀 3.5~4.5 kg, 천궁 3.5~4.5 kg, 자소엽 0.8~1.2 kg 및 맥문동 0.8~1.2 kg을 혼합한 한약재에 물을 8~12배(v/w) 첨가한 후 80~90℃에서 10~14시간 동안 추출하고 여과하여 한약재 추출물을 제조하는 단계;(1) Water was added 8 to 12 times (v / w) to the medicinal herbs mixed with 3.5 to 4.5 kg of Angelica gigas, 3.5 to 4.5 kg of Angelica gigas, 0.8 to 1.2 kg of Liliaceae, For 10 to 14 hours and filtering to prepare a medicinal herb extract;
(2) 상기 (1)단계의 제조한 한약재 추출물 70~90 L에 라임 즙액 8~12 L 및 프로폴리스 추출물 8~12 L를 혼합한 혼합물을 준비하는 단계;(2) preparing a mixture of 70 to 90 L of the herbal medicine extract prepared in the step (1), 8 to 12 L of lime juice and 8 to 12 L of propolis extract;
(3) 도라지를 상기 (2)단계의 준비한 혼합물에 20~25℃에서 5~7시간 동안 침지한 후 꺼내는 단계;(3) immersing the bellflower in a mixture prepared in the step (2) at 20 to 25 ° C for 5 to 7 hours, and then taking out the bellflower;
(4) 상기 (3)단계의 꺼낸 생도라지를 55~60℃에서 20~28시간 동안 건조하는 단계; 및(4) drying the extracted rhizome of step (3) at 55 to 60 DEG C for 20 to 28 hours; And
(5) 상기 (4)단계의 건조한 도라지를 7~10 kg/cm2 압력 및 90~120℃ 온도에서 8~12분 동안 볶고 분쇄한 후 티백에 담아 봉하는 단계를 포함할 수 있으며,(5) frying the dried bellflower of step (4) at a pressure of 7 to 10 kg / cm < 2 > and a temperature of 90 to 120 DEG C for 8 to 12 minutes,
더욱 구체적으로는More specifically,
(1) 당귀 4 kg, 천궁 4 kg, 자소엽 1 kg 및 맥문동 1 kg을 혼합한 한약재에 물을 10배(v/w) 첨가한 후 85℃에서 12시간 동안 추출하고 여과하여 한약재 추출물을 제조하는 단계;(1) Water was added 10 times (v / w) to the medicinal herbs mixed with 4 kg of Angelica giganta, 4 kg of Angelica gigas, 1 kg of Liliaceae and 1 kg of ginseng root and extracted for 12 hours at 85 ° C and filtered to prepare herbal medicine extract ;
(2) 상기 (1)단계의 제조한 한약재 추출물 80 L에 라임 즙액 10 L 및 프로폴리스 추출물 10 L를 혼합한 혼합물을 준비하는 단계;(2) preparing a mixture of 80 L of the medicinal herb extract prepared in the step (1) and 10 L of the lime juice and 10 L of the propolis extract;
(3) 도라지를 상기 (2)단계의 준비한 혼합물에 20~25℃에서 6시간 동안 침지한 후 꺼내는 단계;(3) immersing the bellflower in a mixture prepared in step (2) at 20 to 25 ° C for 6 hours, and then taking out the bellflower;
(4) 상기 (3)단계의 꺼낸 생도라지를 55~60℃에서 24시간 동안 건조하는 단계; 및(4) drying the drawn rhododendrons of the step (3) at 55 to 60 ° C for 24 hours; And
(5) 상기 (4)단계의 건조한 도라지를 8.5 kg/cm2 압력 및 105℃ 온도에서 10분 동안 볶고 분쇄한 후 티백에 담아 봉하는 단계를 포함할 수 있다.(5) frying the dried bellflower at the step (4) at a pressure of 8.5 kg / cm < 2 > and a temperature of 105 DEG C for 10 minutes, and then grinding and sealing the beaker in a tea bag.
본 발명은 또한, 상기 방법으로 제조된 도라지 티백차를 제공한다.The present invention also provides a strawberry tea bag manufactured by the above method.
이하, 본 발명의 바람직한 실시예를 첨부된 실험 결과에 의하여 상세히 설명하면 다음과 같다. 그러나 본 발명은 이하에서 개시되는 실시예에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 수 있으며, 단지 본 실시예는 본 발명의 개시가 완전하도록 하며 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이다.Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying experimental results. The present invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. It is provided to let you know.
제조예Manufacturing example 1. 도라지 1. Bellflower 티백차Tea bag tea
(1) 생도라지 60 kg을 준비하고, 표면의 이물질을 고압세척기로 세척하였다.(1) 60 kg of raw platelets were prepared, and the foreign substances on the surface were washed with a high pressure washer.
(2) 상기 세척한 도라지의 껍질을 70% 이상 잔존시켜 껍질을 포함하는 생도라지를 준비하였다.(2) 70% or more of the washed bellflower was left to prepare a fresh bellflower containing the bark.
(3) 상기 (2)단계의 준비한 생도라지를 2~3 mm 두께로 슬라이스하였다.(3) The prepared rhododendron prepared in the step (2) was sliced to a thickness of 2 to 3 mm.
(4) 당귀 4 kg, 천궁 4 kg, 자소엽 1 kg 및 맥문동을 1 kg을 혼합한 한약재에 물을 10배량 첨가한 후 85℃에서 12시간 동안 추출한 후 여과하여 한약재 추출물을 제조하였다.(4) Water was added 10 times to 4 kg of Angelica japonica, 4 kg of Angelica japonica, 1 kg of Japanese Lobule and 1 kg of Maekmoongdong, and then extracted with water at 85 ℃ for 12 hours and then filtered to produce herbal medicine extract.
(5) 상기 (4)단계의 제조한 한약재 추출물 80 L에 라임(lime) 즙액 10 L 및 프로폴리스 추출물 10 L를 혼합한 혼합물을 준비하였다.(5) A mixture of 10 L of the lime juice and 10 L of the propolis extract was prepared in 80 L of the herbal medicine extract prepared in the step (4).
(6) 상기 (3)단계의 슬라이스한 생도라지를 상기 (5)단계의 준비한 혼합물에 20~25℃에서 6시간 동안 침지한 후 꺼내었다.(6) The sliced rhizome of step (3) was immersed in the mixture prepared in step (5) for 6 hours at 20 to 25 ° C.
(7) 상기 (6)단계의 꺼낸 생도라지를 55~60℃에서 24시간 동안 건조하였다.(7) The prepared rhizome of step (6) was dried at 55 to 60 DEG C for 24 hours.
(8) 상기 (7)단계의 건조한 도라지를 105℃ 온도 및 7~10 kg/cm2 압력에서 10분 동안 볶았다.8 (7) above the dried bellflower temperature of 105 ℃ step and 7 ~ 10 kg / cm 2 Stirred for 10 minutes at pressure.
(9) 상기 (8)단계의 볶은 도라지를 0.5~2 mm의 크기로 분쇄하고 2 g씩 티백에 담아 봉하였다.(9) The roasted bellflower of the above step (8) was pulverized to a size of 0.5 to 2 mm, and then 2 g of the roasted bellflower was placed in a tea bag.
비교예Comparative Example 1. 도라지 1. Bellflower 티백차Tea bag tea
(1) 생도라지 60 kg을 준비하고, 표면의 이물질을 고압세척기로 세척하였다.(1) 60 kg of raw platelets were prepared, and the foreign substances on the surface were washed with a high pressure washer.
(2) 상기 세척한 도라지의 껍질을 70% 이상 잔존시켜 껍질을 포함하는 생도라지를 준비하였다.(2) 70% or more of the washed bellflower was left to prepare a fresh bellflower containing the bark.
(3) 상기 (2)단계의 준비한 생도라지를 2~3 mm 두께로 슬라이스하였다.(3) The prepared rhododendron prepared in the step (2) was sliced to a thickness of 2 to 3 mm.
(4) 상기 (3)단계의 슬라이스한 생도라지를 55~60℃에서 24시간 동안 건조하였다.(4) The sliced rhizome of step (3) was dried at 55 to 60 DEG C for 24 hours.
(5) 상기 (4)단계의 건조한 도라지를 105℃ 온도 및 7~10 kg/cm2 압력에서 10분 동안 볶았다.(5) In above (4) a dry bellflower temperature of 105 ℃ step and 7 ~ 10 kg / cm 2 Stirred for 10 minutes at pressure.
(6) 상기 (5)단계의 볶은 도라지를 0.5~2 mm의 크기로 분쇄하고 2 g씩 티백에 담아 봉하였다.(6) The roasted bellflower of the above step (5) was pulverized to a size of 0.5 to 2 mm, and each 2 g was put in a tea bag and sealed.
비교예Comparative Example 2 및 3: 도라지 2 and 3: Bellflower 티백차Tea bag tea
상기 제조예 1의 방법으로 도라지 티백차를 제조하되, (4)단계의 한약재 혼합 시 표 1의 한약재 종류 및 첨가량으로 혼합한 한약재로 제조한 한약재 추출물을 이용하여 도라지 티백차를 제조하였다.The Doraji tea bag tea was prepared by using the herbal medicine extract made from herb medicinal materials mixed with herbal medicinal materials in Table 1 and the addition amount in the step of preparing the medicinal plant tea by the method of Preparation Example 1 and mixing the herbal medicines in the step (4).
비교예Comparative Example 4 및 5: 도라지 4 and 5: Bellflower 티백차Tea bag tea
상기 제조예 1의 방법으로 도라지 티백차를 제조하되, (5)단계의 혼합물 혼합 시 표 1의 재료 배합비로 혼합한 혼합물을 이용하여 도라지 티백차를 제조하였다.A bellows tea bag tea was prepared using the mixture prepared in the preparation method of Preparation Example 1 at a mixing ratio of materials shown in Table 1 during the mixing of the blend of step (5).
1. 항균 효과 측정1. Antimicrobial effect measurement
호흡기질환을 유발하는 세균에 대한 항균 효과를 측정하였으며, 사용 균주는 스트렙토코커스 피로게네스(Streptococcus pyrogenes KCTC 19615), 크렙시엘라 뉴모니아(Klebsiella pneumonia KCTC 2246), 스타필로코커스 아우레우스(Staphylococcus aureus KCTC 1621), 코리네박테리움 디프테리아(Corynebacterium diphtheriae KCTC 3075) 균주를 사용하였고, 상기 균주는 한국생명공학연구원 미생물자원센터에서 분양받았다. 각 균주를 NB(nutrient broth) 배지에 각각 접종하여 35℃에서 배양한 다음, 102 CFU/mL 농도가 되도록 멸균수로 희석한 균 배양액을 이용하였다.We measured an antibacterial effect against bacteria causing respiratory infections, using strain is Streptococcus fatigue to Ness (Streptococcus pyrogenes KCTC 19615), keurep when Ella pneumoniae (Klebsiella pneumonia KCTC 2246), Staphylococcus aureus (Staphylococcus aureus KCTC 1621), Corynebacterium diphtheriae KCTC 3075) was used, and the strain was distributed at the microbiological resource center of the Korea Research Institute of Bioscience and Biotechnology. Each strain was inoculated into NB (nutrient broth) medium, cultured at 35 ° C, and then diluted with sterilized water to a concentration of 10 2 CFU / ml.
시료 10 g에 물 100 mL를 첨가하여 35℃에서 5시간 동안 추출한 후 여과한 상등액을 배지 90 mL에 10 mL씩 첨가하고, 상기 준비한 각각의 102 CFU/mL 농도의 균 배양액을 각각 0.2 mL씩 주입하고 35℃에서 100 rpm으로 진탕시키면서 균을 24시간 동안 배양하였다. 시간별로 배양한 후 660 ㎚에서 흡광도를 측정하여 균 증식 정도를 확인하였다. 배양액의 흡광도가 660 ㎚에서 0.2 이상 나올 경우, 균 콜로니 수가 106 CFU/mL 이상 나오는 것을 확인하였다.To 10 g of sample, add 100 mL of water, extract at 35 ° C for 5 hours, add 10 mL of the filtered supernatant to 90 mL of medium, and add 0.2 mL of each of the prepared 10 2 CFU / mL And the bacteria were cultured for 24 hours while shaking at 35 rpm at 100 rpm. After incubation with time, the absorbance was measured at 660 ㎚ to confirm the degree of mycelial growth. When the absorbance of the culture broth was more than 0.2 at 660 ㎚, it was confirmed that the number of bacterial colonies was more than 10 6 CFU / mL.
실시예Example 1. 도라지 1. Bellflower 티백차의Tea bag 항균 활성 Antimicrobial activity
제조예 1과 비교예들의 도라지 티백차를 가지고 항균 활성을 측정하였다. 그 결과, 무처리(NB 배지)에 비해 제조예 1 처리구가 스트렙토코커스 피로게네스(Streptococcus pyrogenes) 균에 대해서는 약 4.3배, 크렙시엘라 뉴모니아(Klebsiella pneumonia) 균에 대해서는 약 1.9배, 코리네박테리움 디프테리아(Corynebacterium diphtheriae) 균에 대해서는 약 6.5배 정도 균 증식 억제 지연시간을 나타내었고, 스타필로코커스 아우레우스(Staphylococcus aureus) 균은 제조예 1의 처리구는 검출되지 않아, 제조예 1의 도라지 티백차가 우수한 항균 효과를 나타냄을 확인할 수 있었다(도 1).Antibacterial activity was measured with a Dorago tea bag tea of Preparation Example 1 and Comparative Example. As a result, it was found that about 4.3 times in the case of Streptococcus pyrogenes , about 1.9 times in the case of Klebsiella pneumonia , and in the case of Klebsiella pneumonia , Four bacterium diphtheria ( Corynebacterium diphtheriae strains showed about 6.5 times the delay in inhibiting microbial growth. Staphylococcus aureus strains were not detected in the treatment of Preparation Example 1, and the Dorogi tea bag of Preparation Example 1 had excellent antimicrobial effect (Fig. 1).
실시예Example 2. 도라지 2. Bellflower 티백차Tea bag tea 침출액의 고형분 함량 The solids content of the leachate
제조예 1과 비교예들의 각각의 도라지 티백차에 7℃의 정제수 10배량을 첨가하여 30분 동안 침출한 침출액을 적외선수분계를 이용하여 고형분을 각각 측정하였다. 그 결과, 제조예 1의 티백차 침출액이 고형분 함량이 가장 높게 나타나, 제조예 1의 도라지 티백차는 찬물에서도 잘 우러나 침출 효율이 가장 높게 나타남을 확인할 수 있었다.10% of purified water at 7 ° C was added to each of the blueberry tea bags of Preparation Example 1 and Comparative Examples, and the leached liquid was leached for 30 minutes, and the solid content was measured using an infrared moisture meter. As a result, the solid content of the tea bag tea extract of Production Example 1 was the highest, and the tea leaf tea of Production Example 1 was good even in cold water, and the leaching efficiency was the highest.
실시예Example 3. 도라지 3. Bellflower 티백차의Tea bag 관능검사 Sensory test
제조예 1과 비교예들의 방법으로 제조된 도라지 티백차를 따뜻한 물에 우려낸 후 관능검사 요원 20명을 대상으로 색, 향, 맛 및 전체적인 기호도를 7점 평점법으로 실시하였다. 이때 채점 기준은 매우 좋다; 7점, 좋다; 6점, 좋은편이다; 5점, 보통; 4점, 조금 나쁘다; 3점, 나쁘다; 2점, 아주 나쁘다; 1점으로 하였고, 2시간 간격으로 시료의 번호를 바꾸어 같은 패널로 3회 반복하였으며, 각 반복 시 가장 높은 점수와 가장 낮은 점수를 제외하고 평균 득점을 구하였다.The Doraji tea bag tea prepared by the method of Preparation Example 1 and Comparative Example was applied to warm water, and then the color, flavor, taste and overall acceptability of the 20 sensory test agents were evaluated by the 7-point method. The scoring criteria are very good; 7 points, good; 6 points, good; 5 points, average; 4 points, a little bad; 3 points, bad; 2 points, very bad; 1 point. The number of samples was changed every 2 hours and the same panel was repeated 3 times. The average score was obtained except for the highest score and the lowest score at each iteration.
그 결과, 비교예 1의 도라지 티백차가 가장 낮은 선호도를 나타내었고, 제조에 1의 도라지 티백차가 모든 항목에서 가장 높은 점수를 나타내어, 제조예 1의 도라지 티백차는 색이 진할 뿐만 아니라, 쓴맛은 감소하고 부드러운 풍미가 증가하여 기호도가 높은 것으로 판단된다.As a result, the black tea tea bag of Comparative Example 1 showed the lowest preference, and the black tea tea bag of one showed the highest score in all the items in the production, and the black tea tea of Production Example 1 not only had a color but also decreased the bitter taste It is considered that the preference is high due to the increase in the soft flavor.
Claims (4)
(2) 상기 (1)단계의 제조한 한약재 추출물 70~90 L에 라임 즙액 8~12 L 및 프로폴리스 추출물 8~12 L를 혼합한 혼합물을 준비하는 단계;
(3) 도라지를 상기 (2)단계의 준비한 혼합물에 20~25℃에서 5~7시간 동안 침지한 후 꺼내는 단계;
(4) 상기 (3)단계의 꺼낸 생도라지를 55~60℃에서 20~28시간 동안 건조하는 단계; 및
(5) 상기 (4)단계의 건조한 도라지를 7~10 kg/cm2 압력 및 90~120℃ 온도에서 8~12분 동안 볶고 분쇄한 후 티백에 담아 봉하는 단계를 포함하여 제조하는 것을 특징으로 하는 침출 효율 및 호흡기질환 유발 세균에 대한 항균 활성이 증진된 도라지 티백차의 제조방법.(1) The medicinal herbs mixed with 3.5 ~ 4.5 kg of Angelica gigas, 3.5 ~ 4.5 kg of Angelica gigas Nakai, 0.8 ~ 1.2 kg of Lycaenia lobules and 0.8 ~ 1.2 kg of Gumboongdong were added at 8 ~ 12 times (v / w) Extracting for 10 to 14 hours and filtering to prepare a herbal extract;
(2) preparing a mixture of 70 to 90 L of the herbal medicine extract prepared in the step (1), 8 to 12 L of lime juice and 8 to 12 L of propolis extract;
(3) immersing the bellflower in a mixture prepared in the step (2) at 20 to 25 ° C for 5 to 7 hours, and then taking out the bellflower;
(4) drying the extracted rhizome of step (3) at 55 to 60 DEG C for 20 to 28 hours; And
(5) The step of frying the dried bellflower at the step (4) at a pressure of 7 to 10 kg / cm 2 and a temperature of 90 to 120 ° C for 8 to 12 minutes, And the antibacterial activity against respiratory disease-causing bacteria is enhanced.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180061883A KR101990456B1 (en) | 2018-05-30 | 2018-05-30 | Method for producing balloonflower tea of teabag-type and balloonflower tea of teabag-type produced by the same method |
| PCT/KR2019/006435 WO2019231236A1 (en) | 2018-05-30 | 2019-05-29 | Method for preparing bellflower root tea bags, and bellflower root tea bags prepared by method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180061883A KR101990456B1 (en) | 2018-05-30 | 2018-05-30 | Method for producing balloonflower tea of teabag-type and balloonflower tea of teabag-type produced by the same method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR101990456B1 true KR101990456B1 (en) | 2019-07-09 |
Family
ID=67261054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020180061883A KR101990456B1 (en) | 2018-05-30 | 2018-05-30 | Method for producing balloonflower tea of teabag-type and balloonflower tea of teabag-type produced by the same method |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR101990456B1 (en) |
| WO (1) | WO2019231236A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210056626A (en) | 2019-11-11 | 2021-05-20 | (주)코레쉬텍 | Platycodon grandiflorum tea composition with reduced browning and carbonization due to heat, and manufacturing method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010084854A (en) * | 2000-02-29 | 2001-09-06 | 문혜연 | Functional food containing extract of Platycodon grandiflorusjacqin A De Candolle and process and for preparation thereof |
| KR20020096925A (en) * | 2001-06-15 | 2002-12-31 | 주식회사 장생도라지 | Composition for preventing and treating a degenerative brain disease or for the enhancement of memory comprising an extract of the root of balloon-flower |
| KR20060116596A (en) * | 2005-05-10 | 2006-11-15 | (주)토종물산 | Health beverage composition comprising an extract of platycodon grandiflorum, glycyrrhiza uralensis, liriope platyphylla and chaenomeles sinesis koehne for preventing a respiratory disease |
| KR20140079096A (en) * | 2012-12-18 | 2014-06-26 | 웅진식품주식회사 | Fruit juice-containing composition comprising Propolis abstract, and method of preparing the same |
| KR20170055758A (en) * | 2015-11-12 | 2017-05-22 | (주) 벤우코리아 | Anti inflammatory comprising plant extract |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100896959B1 (en) * | 2009-01-02 | 2009-05-12 | 꽃뫼영농조합법인 | Liriope platyphylla tea bag |
-
2018
- 2018-05-30 KR KR1020180061883A patent/KR101990456B1/en active IP Right Grant
-
2019
- 2019-05-29 WO PCT/KR2019/006435 patent/WO2019231236A1/en active Application Filing
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010084854A (en) * | 2000-02-29 | 2001-09-06 | 문혜연 | Functional food containing extract of Platycodon grandiflorusjacqin A De Candolle and process and for preparation thereof |
| KR20020096925A (en) * | 2001-06-15 | 2002-12-31 | 주식회사 장생도라지 | Composition for preventing and treating a degenerative brain disease or for the enhancement of memory comprising an extract of the root of balloon-flower |
| KR20060116596A (en) * | 2005-05-10 | 2006-11-15 | (주)토종물산 | Health beverage composition comprising an extract of platycodon grandiflorum, glycyrrhiza uralensis, liriope platyphylla and chaenomeles sinesis koehne for preventing a respiratory disease |
| KR20140079096A (en) * | 2012-12-18 | 2014-06-26 | 웅진식품주식회사 | Fruit juice-containing composition comprising Propolis abstract, and method of preparing the same |
| KR20170055758A (en) * | 2015-11-12 | 2017-05-22 | (주) 벤우코리아 | Anti inflammatory comprising plant extract |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210056626A (en) | 2019-11-11 | 2021-05-20 | (주)코레쉬텍 | Platycodon grandiflorum tea composition with reduced browning and carbonization due to heat, and manufacturing method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019231236A1 (en) | 2019-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101467837B1 (en) | Manufacturing method of fermented red ginseng extract with enhanced ginsenosides Rg3 and antioxidant activity | |
| CN104351586A (en) | Cattle mixed feed and preparation method thereof | |
| KR102436582B1 (en) | A process for the preparation of Manufacturing method of bellflower syrup and the bellflower syrup prepared therefrom | |
| KR101705545B1 (en) | Composition for preventing respiratorydisease, immune-enhancing, anti-obesity containing fermented Platycodon grandiflorum | |
| KR101013203B1 (en) | An antibacterial composition and a method for preparing the same | |
| KR101990456B1 (en) | Method for producing balloonflower tea of teabag-type and balloonflower tea of teabag-type produced by the same method | |
| KR101983232B1 (en) | Health supplement food using sparassis crispa and manufacturing method thereof | |
| KR20180018073A (en) | Livestock feed additives for substituting antibiotics and manufacturing method thereof | |
| KR102082649B1 (en) | Method for producing balloonflower pear syrup and balloonflower pear syrup produced by the same method | |
| CN105943679A (en) | Traditional Chinese medicine probiotic compound preparation for poultry and preparation method thereof | |
| CN113975357B (en) | Traditional Chinese medicine composition for clearing lung, eliminating phlegm, eliminating carbuncle, expelling pus, clearing heat and promoting diuresis and application thereof | |
| KR101815547B1 (en) | Platycodon grandiflorum mixture tablet with increased antibacterial activity against respiratory disease-inducing bacteria | |
| CN104666437A (en) | Preparation method of black pepper | |
| KR100824035B1 (en) | Method for Controlling bacteria relating to a fermentation of Kimchi by using a blend that consists of Green tea, Dandelion and Vegetable worms | |
| KR20150067822A (en) | Functional composition for comprising wild-peach and the manufacturing method thereof | |
| KR102063447B1 (en) | Balloonflower syrup for child | |
| CN109007965B (en) | Liupu tea cigarette and making method thereof | |
| CN113383834A (en) | A health black tea containing Curcuma rhizome and Glycyrrhrizae radix, and its preparation method | |
| KR101301546B1 (en) | Functional fermentation composition having anti-inflammatory effect of fermented mixed plants(wild plant dln-28) using sugar-free fermentation | |
| CN109043316A (en) | A kind of nourishing the stomach flour, preparation method and wheaten food | |
| CN110859288A (en) | Preparation method of dendrobium officinale betel nut with effect of improving oral micro-ecology | |
| KR102201601B1 (en) | The balloonflower syrup bloomed | |
| CN115006496B (en) | Chinese herbal medicine composition for treating pneumonia of foxes, raccoon dogs and martens | |
| KR20200042639A (en) | Method for producing Jocheong using Canavalia ensiformis and Lufa cylindrica | |
| KR20120128394A (en) | Noodle composition comprising juice extraction of milk vetch |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GRNT | Written decision to grant |